Year Founded
2021
Ownership
Private
Employees
~50
Stage
Preclinical
Modalities
Gene therapySmall molecule

Mirai Bio General Information

Platform company focused on developing end-to-end genetic medicine development capabilities using machine intelligence for optimizing delivery, design and manufacturing

Contact Information

Website
Primary Industry
Biotech
Corporate Office

Drug Pipeline

No pipeline data available

For full access to Mirai Bio's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Mirai Bio Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Mirai Bio's complete valuation and funding history, request access »

Mirai Bio Investors

Flagship Pioneering (initial commitment of $50 million)
Investor Type: Venture Capital
Holding: Minority